Oxidative Medicine and Cellular Longevity / 2022 / Article / Tab 1 / Research Article
[Retracted] Recurrence of Early Hepatocellular Carcinoma after Surgery May Be Related to Intestinal Oxidative Stress and the Development of a Predictive Model Table 1 Baseline characteristics.
Train ( ) Test ( ) valueGender: 0.482 Female 7 (9.86%) 2 (4.88%) Male 64 (90.1%) 39 (95.1%) Age 50.3 (9.65) 52.5 (10.3) 0.260 BMI 23.7 (3.88) 23.0 (2.71) 0.290 Child pugh: 1.000 A 70 (98.6%) 41 (100%) B 1 (1.41%) 0 (0.00%) Hepatitis_B: 0.036 Others 3 (4.23%) 7 (17.1%) Yes 68 (95.8%) 34 (82.9%) AFP 4.81 (2.64) 3.97 (2.56) 0.101 DCP 5.32 (2.47) 4.81 (2.78) 0.336 BCLC: 0.470 0 6 (8.45%) 1 (2.44%) A 60 (84.5%) 38 (92.7%) B 5 (7.04%) 2 (4.88%) CNLC: 0.751 Ia 38 (53.5%) 24 (58.5%) Ib 33 (46.5%) 17 (41.5%) Tumor_number: 0.264 Multiple 14 (19.7%) 4 (9.76%) Single 57 (80.3%) 37 (90.2%) Maximum_diameter 3.70 [2.50; 5.65] 3.50 [2.50; 6.00] 0.849 Tumor_location: 0.539 Left 16 (22.5%) 6 (14.6%) Middle 6 (8.45%) 5 (12.2%) Right 49 (69.0%) 30 (73.2%) Hilar_occlusion_time 37.5 [34.5; 55.5] 31.0 [22.0; 42.0] 0.005 Time_of_operation 245 [207; 308] 245 [215; 299] 0.878 Bleeding 200 [100; 375] 200 [100; 300] 0.831 Operation_method: 0.539 Laparoscopic 28 (39.4%) 13 (31.7%) Open 43 (60.6%) 28 (68.3%) Pathology_classification: 0.410 1&2_grade 31 (43.7%) 22 (53.7%) 3&4_grade 40 (56.3%) 19 (46.3%) MVI: 0.437 No 53 (74.6%) 34 (82.9%) Yes 18 (25.4%) 7 (17.1%) Cirrhosis: 0.541 No 52 (73.2%) 27 (65.9%) Yes 19 (26.8%) 14 (34.1%) RFS 2.13 (0.91) 2.02 (0.86) 0.535 Recrudescence 0.21 (0.41) 0.24 (0.43) 0.697 Otu_score -0.17 [-0.48; 0.32] -0.36 [-0.48; 0.16] 0.393 Ra_score -0.04 [-0.56; 0.48] 0.01 [-1.20; 0.52] 0.548